TENNIS ANTI-DOPING PROGRAMME
Decision In The Case Of Robert Kendrick
by Press Release|
The International Tennis Federation announced that the Court of Arbitration for Sport (CAS) has partially upheld the appeal by Robert Kendrick against the decision of the independent tribunal dated 29 July 2011.
The independent tribunal had determined that Mr Kendrick should be suspended from participation for a period of 12 months, commencing from 22 May 2011 and so ending at midnight on 21 May 2012 for the commission of an Anti-Doping Rule Violation under Article C.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s sample).
The CAS panel decided that the independent tribunal’s decision be set aside, and replaced with a period of ineligibility of eight months, with the start back-dated to 22 May 2011, the date on which the positive sample was provided. He thus will be eligible to participate on 22 January 2012.
Mr Kendrick’s results from Roland Garros remain disqualified, including forfeiture of the prize money and ranking points won at that event. Mr Kendrick is permitted to retain the prize money won at the UNICEF Open in s’-Hertogenbosch.
The full decision, with reasons, will follow in due course.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at tournaments sanctioned by the ITF, ATP and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.